Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sporadic Papillary Renal Cell Cancer”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT01130519
What this trial is testing

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

Who this might be right for
HLRCCSporadic Papillary Renal Cell Cancer
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Study completedNCT00726323
What this trial is testing

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 74
Testing effectiveness (Phase 2)Looking for participantsNCT04981509
What this trial is testing

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Who this might be right for
Hereditary Leiomyomatosis and Renal Cell CarcinomaPapillary Renal Cell CarcinomaRenal Cell Carcinoma+3 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Ended earlyNCT02495103
What this trial is testing

Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaHereditary LeiomyomatosisRenal Cell Cancer
National Cancer Institute (NCI) 7